GlassScriptPhysician profile
Arash Aghel
NPI 1477729713
$5,372.87
in general payments reported to CMS, 2019-2025
39 companies · $1,476 in 2025
The $1,476 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $403 · 2020: $317 · 2021: $194 · 2022: $436 · 2023: $1,152 · 2024: $1,396 · 2025: $1,476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,023.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,023.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $999.16 | 2019-2025 | Avvigo Guidance System, Rotapro, Comet |
| Edwards Lifesciences Corporation | $801.81 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Pfizer INC. | $398.94 | 2023-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $361.36 | 2019-2025 | Lifevest |
| Cardiovascular Systems INC. | $333.12 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $279.88 | 2019-2025 | |
| Philips North America LLC | $253.54 | 2022 | |
| Medtronic, INC. | $252.36 | 2022-2025 | Closurefast, Venaseal, Symplicity G3 |
| Janssen Pharmaceuticals, INC | $199.09 | 2019-2024 | Xarelto |
| Inari Medical, INC. | $176.24 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amgen INC. | $174.80 | 2019-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.81 | 2023-2025 | Jardiance, Spiriva Respimat, Stiolto Respimat |
| Recor Medical INC | $107.55 | 2025 | Paradise Ultrasound Renal Denervation System |
| Regeneron Healthcare Solutions, INC. | $97.29 | 2022-2025 | Evkeeza |
| Astrazeneca Pharmaceuticals LP | $89.01 | 2023-2025 | Farxiga, Wainua |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arash Aghel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.